Professor Elisabeth Vandenberghe
Clinical Professor, Haematology
Consultant, School Office - Medicine
Publications and Further Research Outputs
Peer-Reviewed Publications
Carmel Waldron,David O'Brien,Sarah Brophy,Kanthi Perera,Gerard M. Crotty,Eoghan Dunlea,Aileen Walsh,Michelle Connolly,Ruth Clifford,Hilary O'Leary,Ashique Khan,Greg Lee,Emer Atkinson,Giao Le,Alexander Gillett,Christopher L. Bacon,Anthony M. McElligott,Fiona Quinn,Elisabeth Vandenberghe, Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning, British Journal of Haematology, 2021
Avivi, I., Boumendil, A., Finel, H., Nagler, A., de Sousa, A.B., Santasusana, J.M.R., Vandenberghe, E., Afanasyev, B., Bordessoule, D., Moraleda, J.M., Garcia, E.C., Pohlreich, D., Garcia, G.G., Thomson, K., Or, R., Beelen, D., Zuffa, E., Giebel, S., Berthou, C., Salles, G., Melpignano, A., Montoto, S., Dreger, P., Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation, Bone Marrow Transplantation, 2018, p1-9
Dreger, P., Michallet, M., Bosman, P., Dietrich, S., Sobh, M., Boumendil, A., Nagler, A., Scheid, C., Cornelissen, J., Niederwieser, D., Müller, L., Vandenberghe, E., Scortechini, I., Schoemans, H., Andersen, N.S., Finke, J., Russo, D., Ljungman, P., Passweg, J., van Gelder, M., Durakovic, N., Labussiere-Wallet, H., Berg, T., Wulf, G., Bethge, W., Bunjes, D., Stilgenbauer, S., Canepari, M.E., Schaap, M., Fox, C.P., Kröger, N., Montoto, S., Schetelig, J., Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties, Bone Marrow Transplantation, 2018, p1-9
Appleby, N., O"Brien, D., Quinn, F.M., Smyth, L., Kelly, J., Parker, I., Scott, K., Cahill, M.R., Crotty, G., Enright, H., Hennessy, B., Hodgson, A., Leahy, M., O"Leary, H., O"Dwyer, M., Hayat, A., Vandenberghe, E.A., Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL, Leukemia and Lymphoma, 59, (6), 2018, p1338-1347
Frawley, T., O'Brien, C.P., Conneally, E., Vandenberghe, E., Percy, M., Langabeer, S.E., Haslam, K., Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms, Genetic Testing and Molecular Biomarkers, 22, (2), 2018, p98-103
Ghnewa YG, O'Reilly VP, Vandenberghe E, Browne PV, McElligott AM, Doherty DG, Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8+ invariant natural killer T cells, Clinical Immunology, 183, 2017, p91 - 98
Eyre, T.A., Osborne, W.L., Gallop-Evans, E., Ardeshna, K.M., Kassam, S., Sadullah, S., Sidra, G., Culligan, D., Arumainathan, A., Shankara, P., Bowles, K.M., Eyre, D.W., Peng, Y.Y., Pettengell, R., Bloor, A., Vandenberghe, E., Collins, G.P., Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma, British Journal of Haematology, 2017
Elhassadi E, Flavin R, Browne P, Conneally E, Hayden P, Quinn F, Higgins E, Vandenberghe E, Transformed follicular lymphoma (tFL): consolidation therapy may improve survival, Irish Journal of Medical Science, 1863, 2017, p589-595
Jones, J.A., Robak, T., Brown, J.R., Awan, F.T., Badoux, X., Coutre, S., Loscertales, J., Taylor, K., Vandenberghe, E., Wach, M., Wagner-Johnston, N., Ysebaert, L., Dreiling, L., Dubowy, R., Xing, G., Flinn, I.W., Owen, C., Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial, The Lancet Haematology, 4, (3), 2017, pe114-e126
Ryan C, Ged Y, Quinn F, Walker J, Kennedy J, Gillham C, Pittaluga S, McDermott R, Vandenberghe E, Grant C, Flavin R, Classical Hodgkin Lymphoma Arising Adjacent to a Breast Implant., 2016
Marchand T, Lamy T, Finel H, Arcese W, Choquet S, Finke J, Huynh A, Irrera G, Karakasis D, Konopacki J, Lambert J, Michieli M, Schouten HC, Schroyens W, Sucak G, Tischer J, Vandenberghe E, Dreger P, Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation., 2016
Dowling AK, Liptrot SD, O'Brien D, Vandenberghe E, Optimization and Validation of an 8-Color Single-Tube Assay for the Sensitive Detection of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia Detected via Flow Cytometry., 2016
McGovern B, Quinn F, Andrews C, Jeffers M, Bacon CL, Bird B, Crotty G, Vandenberghe E, Flavin R, NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia., 2016
O'Kane G, Bracken-Clarke D, Gardiner N, Lee G, Ni Chonghaile M, Power D, Daly PA, McCaffrey J, Bacon CL, Conneally E, Flynn C, Vandenberghe E, Kennedy MJ, Browne PV, O'Donnell DM, Hayden PJ, A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen., 2016
Smyth L, Browne PV, Conneally E, Flynn C, Hayden P, Jeffers M, O'Brien D, Quinn F, Kelly J, Perera M, Crotty GM, Leahy M, Hennessy B, Jackson F, Ryan M, Vandenberghe E, Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL., 2016
Sarah Brophy , Fiona M Quinn, David O'Brien, Paul Browne, Elisabeth A. Vandenberghe , Anthony M. McElligott, The Regulation of STAT3 and Its Role in the Adhesion and Migration of Chronic Lymphocytic Leukaemia Cells, Blood, American Society of Hematology Annual Meeting, San Diego, CA, USA, 3-6, December, 201, 128, (22), American Society of Hematology, 2016, pp4347-
Haslam K, Langabeer SE, Hayat A, Conneally E, Vandenberghe E, Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia., 2016
Murray C, Quinn F, Illyes G, Walker J, Castriciano G, O'Sullivan P, Grant C, Vandenberghe E, Bird B, Flavin R, Composite Blastoid Variant of Mantle Cell Lymphoma and Classical Hodgkin Lymphoma., 2016
Tanase A, Schmitz N, Stein H, Boumendil A, Finel H, Castagna L, Blaise D, Milpied N, Sucak G, Sureda A, Thomson K, Vandenberghe E, Vitek A, Dreger P, Lymphoma Working Party of the EBMT, Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party., 2015
Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, Bairey O, Hillmen P, Bartlett NL, Li J, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre S, Quach H, Gaidano G, Maslyak Z, Stevens DA, Janssens A, Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia., 2015
Maguire A, Castriciano G, Walker J, Molloy K, Quinn F, Osman N, Vandenberghe E, Jeffers M, Gaffney E, Flavin R, Case Study: Diffuse Large B-Cell Lymphoma Arising in Ovarian Mature Cystic Teratoma., 2015
Laura Christine Kickham, Anthony M McElligott, Adriele Prina-Mello, Elisabeth A Vandenberghe, Yuri Volkov, Paul Browne, Interrogating the Interaction of CD52 Functionalised Metallic Nanoparticles with Malignant B Lymphocytes, 126, (23), 2015
Brophy S et al, Microenvironmental-Mediated Regulation of L-Selectin in Chronic Lymphocytic Leukaemia, Blood, American Society of Hematology Annual Meeting, Orlando, FL, USA, 5-8 December, 2015, 126, (23), American Society of Hematology, 2015, pp4133 - 4133
Cattaneo C, Finel H, McQuaker G, Vandenberghe E, Rossi G, Dreger P, Autologous hematopoietic stem cell transplantation for plasmablastic lymphoma: the European Society for Blood and Marrow Transplantation experience., 2015
Lyons J, Vandenberghe E, Fahy R, McDonnell C, Keane J, McLaughlin AM, An unusual lung mass post stem cell transplantation., Transplant infectious disease : an official journal of the Transplantation Society, 16, (4), 2014, p672-675
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia., 2014
Fahy CM, Fortune A, Quinn F, McMenamin ME, Browne PV, Langabeer S, McCarron S, Hayden P, Marren P, Ni Chonghaile M, Irvine AD, Vandenberghe E, Barnes L, Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia; transmission from allogeneic donor., The British journal of dermatology, 2013
Liptrot S, O' Brien D, Langabeer SE, Quinn F, Mackarel AJ, Elder P, Vandenberghe E, Hayden PJ, An immunophenotypic and molecular diagnosis of composite hairy cell leukaemia and chronic lymphocytic leukaemia., 2013
Richardson SE, Khan I, Rawstron A, Sudak J, Edwards N, Verfuerth S, Fielding AK, Goldstone A, Kottaridis P, Morris E, Benjamin R, Peggs KS, Thomson KJ, Vandenberghe E, Mackinnon S, Chakraverty R, Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia., 2013
Langabeer SE, Quinn F, O'Brien D, McElligott AM, Kelly J, Browne PV, Vandenberghe E, Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia., Leukemia research, 36, (4), 2012, p483-4
Vandenberghe, E., Primary gastrointestinal lymphomas, Experimental Oncology, 34, (4), 2012, p385-386
Langabeer SE, O'Brien D, Liptrot S, Flynn CM, Hayden PJ, Conneally E, Browne PV, Vandenberghe E, Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype., International Journal of laboratory Hematology, 34, (4), 2012, p417-21
Maginn EN, Browne PV, Hayden P, Vandenberghe E, McDonagh B, Evans P, Goodyer M, Tewari P, Campiani G, Butini S, Williams DC, Zisterer DM, Lawler MP, McElligott AM., PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells., British Journal of Cancer, 104, (2), 2011, p281 - 289
Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E, Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion., 2011
Fortune AF, Kelly K, Sargent J, O'Brien D, Quinn F, Chadwick N, Flynn C, Conneally E, Browne P, Crotty GM, Thornton P, Vandenberghe E, Large granular lymphocyte leukemia: natural history and response to treatment., Leukemia & Lymphoma, 51, (5), 2010, p839 - 845
Fortune A, O'Leary H, Gilmore R, Chadwick N, Brennan L, Ní Chonghaile M, McCann SR, Browne PV, Conneally E, Vandenberghe E, T-lymphoblastic leukemia/lymphoma: a single center retrospective study of outcome., 2010
Haslam K, Chadwick N, Kelly J, Browne P, Vandenberghe E, Flynn C, Conneally E, Langabeer SE, Incidence and significance of FLT3-ITD and NPM1 mutations in patients with normal karyotype acute myeloid leukaemia., Irish journal of medical science, 179, (4), 2010, p507-10
McElligott AM, Maginn EN, Greene LM, McGuckin S, Hayat A, Browne PV, Butini S, Campiani G, Catherwood MA, Vandenberghe E, Williams DC, Zisterer DM, Lawler M, The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia., 2009
Hayat A, McGuckin S, Conneally E, Brown PV, McCann SR, Lawler M, Quinn F, Delaney E, O'Rourke P, Liptrot S, O'Brien D, Vandenberghe E, Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia., Irish journal of medical science, 178, (4), 2009, p441-6
Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E, O'Riordan J, Locasciulli A, Socié G, Kelly A, Schrezenmeier H, Marin P, Tichelli A, Passweg JR, Dickenson A, Ryan J, Bacigalupo A; Severe Aplastic Anaemia Working Party of the European Blood and Marrow Transplant Group., Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA., British Journal of Haematology, 144, (6), 2009, p933-945
Bacon CL, Daly P, Sheane B, Conneally EC, Browne PV, McCann S, Ni Chongaile M, O'Brian DS, Mc Dermott R, Hollywood D, Wilson L, Vandenberghe E, Successful outcome of patients with relapsed/refractor Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St. James's Hospital., Irish medical journal, 102, (1), 2009, p26-8
Zinzani PL, d'Amore F, Bombardieri E, Brammer C, Codina JG, Illidge T, Jurczak W, Linkesch W, Morschhauser F, Vandenberghe E, Van Hoof A, Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop., 2008
Hayat A., O'Brien, D., O'Rourke P., McGuckin S., Fitzgerald S., Conneally E., Browne P., McCann S., Lawler M., Vandenberghe E.., CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia., Leukemia & Lymphoma, 47, (11), 2006, p2371 - 2379
O'Donghaile D, Hayden PJ, McCarron SL, Doyle EM, Lawler M, Browne PV, Conneally E, Vandenberghe E, McCann SR., Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor., European Journal of Haematology, 76, (3), 2006, p258-260
Power M, Vandenberghe E, Browne PV, Kilmartin D, O'Connor M, Sheehy N, McCann S., Retinal and Cerebral Toxoplasmosis following Non-Myeloablative Stem Cell Transplant for Chronic Lymphocytic Leukaemia., Bone Marrow Transplantation, 36, (11), 2005, p735 - 736
Hayden PJ, O'Driscoll A, Gardiner N, Swords R, Sargent J, Ni Ainghle F, Fortune A, Murphy PT, Leahy M, Jackson F, Ryan M, Hennessy B, Cahill M, Crotty G, Enright H, Conneally E, Vandenberghe E, McCann SR and Browne PV. , Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003., Irish Journal of Medical Science, Apr-June 174, (2), 2005, p26 - 32
Hayden PJ, Crampe M, Lawler M, Conneally E, McCann SR, Vandenberghe E, Browne PV., Use of DLI to achieve complete donor chimerism in a patient receiving systemic immunosuppression for refractory AIHA post-NST., Bone Marrow Transplantation, 36, 2005, p735 - 736
Hayden PJ, Keogh F, Ni Conghaile M, Carroll M, Crowley M, Fitzsimon N, Gardiner N, Vandenberghe E, O'Riordan J, McCann SR, A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase., 2004
Vandenberghe E, Ruiz de Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Biesen K, Rizzo JD, Weisenburger DD, Isaacson P, Horowitz MM, Goldstone AH, Lazarus HM, Schmitz N, Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries., 2003
Allen JE, Hough RE, Goepel JR, Bottomley S, Wilson GA, Alcock HE, Baird M, Lorigan PC, Vandenberghe EA, Hancock BW, Hammond DW, Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization., 2002
Sokol RJ, Stamps R, Booker DJ, Scott FM, Laidlaw ST, Vandenberghe EA, Barker HF, Posttransplant immune-mediated hemolysis., 2002
Marks DI, Lush R, Cavenagh J, Milligan DW, Schey S, Parker A, Clark FJ, Hunt L, Yin J, Fuller S, Vandenberghe E, Marsh J, Littlewood T, Smith GM, Culligan D, Hunter A, Chopra R, Davies A, Towlson K, Williams CD, The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation., 2002
Sampson FC, Beard SM, Scott F, Vandenberghe E, Cost-effectiveness of high-dose chemotherapy in first-line treatment of advanced multiple myeloma., 2001
Wilson GA, Vandenberghe EA, Pollitt RC, Rees DC, Goodeve AC, Peake IR, Reilly JT, Are aberrant BCR--ABL transcripts more common than previously thought?, 2000
Abu-Duhier FM, Goodeve AC, Wilson GA, Gari MA, Peake IR, Rees DC, Vandenberghe EA, Winship PR, Reilly JT, FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group., 2000
Hough, R.E., Wilson, G.A., Laidlaw, S.T., Suvarna, S.K., Vandenberghe, E.A., Primary follicular non-hodgkins lymphoma (NHL) of bone, Blood, 96, (11 PART II), 2000
Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J, McMullan DJ, Griffiths MJ, Reilly JT, Vandenberghe EA, Wilson G, Watmore AE, Bown NP, Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia., 2000
Gari M, Goodeve A, Wilson G, Winship P, Langabeer S, Linch D, Vandenberghe E, Peake I, Reilly J, c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia., 1999
Wilson G, Frost L, Goodeve A, Vandenberghe E, Peake I, Reilly J, BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia., 1997
P McGettigan, EE Mooney, M Sinnott, EC Sweeney, J Feely, Sudden death in Whipple's disease, Postgraduate Medical Journal, (73), 1997, p509 - 511
Vandenberghe E, De Wolf-Peeters C, Vaughan Hudson G, Vaughan Hudson B, Pittaluga S, Anderson L, Linch DC, The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group., 1997
Vandenberghe E, Pearce R, Taghipour G, Fouillard L, Goldstone AH, Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry., 1997
Vandenberghe EA, Goldstone AH, Autologous stem cell transplants in lymphomas., 1996
Vandenberghe E, Mantle cell lymphoma., 1994
Vandenberghe E, Van Hove J, Brock P, Schmidt P, Delabie J, Casteels-Van Daele M, Cassiman JJ, Vanderschueren-Lodeweyckx M, Van den Berghe H, Non-endemic Burkitt's lymphoma in a patient with Bloom's syndrome., 1993
Liesner RJ, Vandenberghe EA, Davies SC, Analgesics in sickle-cell disease., 1993
Cuneo A, Michaux JL, Ferrant A, Van Hove L, Bosly A, Stul M, Dal Cin P, Vandenberghe E, Cassiman JJ, Negrini M, Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers., 1992
Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C, Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype., 1992
Criel A, Billiet J, Vandenberghe E, van den Berghe H, Louwagie A, Hidajat M, Vanhoof A, Leukaemic intermediate lymphocytic lymphomas: analysis of twelve cases diagnosed by morphology., 1992
Wlodarska I, Mecucci C, Vandenberghe E, De Wolf-Peeters C, Thomas J, Hilliker C, Schoenmakers E, Stul M, Marynen P, Cassiman JJ, dup(12)(q13----qter) in two t(14;18)-negative follicular B-non-Hodgkin's lymphomas., 1992
Vandenberghe E, De Wolf Peeters C, Wlodarska I, Stul M, Louwagie A, Verhoef G, Thomas J, Criel A, Cassiman JJ, Mecucci C, Chromosome 11q rearrangements in B non Hodgkin's lymphoma., 1992
Vandenberghe E, Baens M, Stul M, Bosly A, Cassiman JJ, Mecucci C, Van den Berghe H, Alteration of N-ras mutation in a patient with AML M4 and trilineage myelodysplasia., 1991
Cuneo A, Gretel Carli M, Piva N, Fagioli F, Vandenberghe E, Dal Cin P, Castoldi G, Van Den Berghe H, Clinicopathological evolution and multilineage involvement in erythroleukemia: report of a case., 1991
Delabie J, De Wolf-Peeters C, De Vos R, Vandenberghe E, Kennes K, De Jonge I, Desmet V, True histiocytic neoplasm of Langerhans' cell type., 1991
Vandenberghe E, Martiat P, Baens M, Stul M, Ferrant A, Cuneo A, Cassiman JJ, Mecucci C, Van den Berghe H, Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome., 1991
Vandenberghe E, van den Oord J, Mecucci C, Van den Berghe H, De Wolf-Peeters C, B-cell non-Hodgkin's lymphomas of follicle mantle lineage: part of a biological spectrum?, 1991
Vandenberghe E, De Wolf-Peeters C, van den Oord J, Wlodarska I, Delabie J, Stul M, Thomas J, Michaux JL, Mecucci C, Cassiman JJ, Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage., 1991
Vandenberghe E, de Wolf-Peeters C, Delabie J, Thomas J, Michaux JL, Noël H, Mecucci C, Van Den Berghe H, Cytogenetic characterization of three cases of unusual B-cell non-Hodgkin's lymphoma., 1991
Busschots AM, Mecucci C, Stul M, Vandenberghe E, Michaux JL, Noel H, Cassiman JJ, Van Den Berghe H, Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL., 1991
Kerim S, Stul M, Mecucci C, Vandenberghe E, Cuneo A, Dal Cin P, Michaux JL, Louwagie A, Cassiman JJ, Van den Berghe H, Rearrangement of immunoglobulin and TCR genes in lymphoid blast crisis of Ph+ chronic myeloid leukaemia., 1990
Vandenberghe EA, Mecucci C, Delannoy A, Van den Berghe H, Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome., 1990
Kerim, S., Mecucci, C., Cuneo, A., Vandenberghe, E., Louwagie, A., Stul, M., Michaux, J.-L., Van Den Berghe, H., 5q - Anomaly in lymphoid disorders, Leukemia, 4, (1), 1990, p12-15
Kerim S, Mecucci C, Cuneo A, Vandenberghe E, Louwagie A, Stul M, Michaux JL, Van Den Berghe H, 5q- anomaly in lymphoid disorders., 1990
Cuneo A, Mecucci C, Kerim S, Vandenberghe E, Dal Cin P, Van Orshoven A, Rodhain J, Bosly A, Michaux JL, Martiat P, Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients., 1989
Cuneo A, Kerim S, Vandenberghe E, Van Orshoven A, Rodhain J, Bosly A, Zachee P, Louwagie A, Michaux JL, Dal Cin P, Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement., 1989
Vandenberghe E, Staines A, Breatnach F, O'Meara A, Recent experience with intensive combination chemotherapy for treatment of childhood acute lymphoblastic leukaemia., 1989
Research Expertise
Projects
- Title
- Role of FISH analysis in Chronic Lymphocytic Leukaemia prognosis '
- Summary
- Fellowship, 2001 Principal Investigator E60, 000.00
- Funding Agency
- Bone Marrow for Leukaemia Trust
- Date From
- 2001
- Date To
- 2002
- Title
- Prognostic Factors in Chronic Lymphocytic Leukaemia
- Summary
- Assessing the impact of immunophenotype, cytogenetic and molecular status on the clinical behaviour of the st James Hospital c Chronic Lymphocytic Leukaemia cohort
- Funding Agency
- Health Research Board
- Date From
- 2002
- Date To
- 2004
- Title
- The clinical implications of molecular analysis of coeliac disease, refractory celiac disease and enteropathy-associated T cell lymphoma (EATCL).
- Summary
- Analysis of the T cell receptor clonality status in duodenal biopsies and blood correlated with morphology and immunophenotype to determine the relationship between coeliac disease, refractory coeliac disease and enteropathy associated T cell lymphoma
- Funding Agency
- Bone Marrow for Leukaemia Trust
- Date From
- 2006
- Date To
- 2007
- Title
- TP53 mutation testing in CLL in Ireland: a template for the introduction of treatment defining molecular assays
- Summary
- Gilead UK and Ireland Fellow ship 2016 TP53 mutation testing in CLL in Ireland: a template for the introduction of treatment defining molecular assays
- Funding Agency
- Gilead
- Date From
- November 2016
- Date To
- April 2017
Recognition
Memberships
American Society of Haematology
Member of the Lymphoma Working Party of the European Blood and Marrow Transplant (EBMT) Group
Chairman of the lymphoma Forum Of Ireland
Chairman of the haematology and lymphoma sub group of ICORG (Clinical Trials Ireland)